2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Breast Neoplasms
8
Colorectal Neoplasms
4
Pancreatic Neoplasms
3
Ovarian Neoplasms
2
Lung Neoplasms
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Peripheral Nervous System Diseases
1
Pain
1
Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Diseases
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma, Intraductal, Noninfiltrating
1
Cancer Cachexia
1
Cachexia
1
Breastcancer
1
Breast Carcinoma In Situ
1
Biliary Tract Neoplasms
1
Interventions
Gemcitabine
94
Cisplatin
71
Capecitabine
39
Oxaliplatin
38
durvalumab
29
Fluorouracil
27
pembrolizumab
26
Leucovorin
23
S 1 (combination)
19
Nivolumab
14
Irinotecan
14
lenvatinib
13
Bevacizumab
11
tremelimumab
10
130-nm albumin-bound paclitaxel
9
apatinib
8
Trastuzumab
7
Injections
7
Immune Checkpoint Inhibitors
7
Docetaxel
7
Albumin-Bound Paclitaxel
7
Paclitaxel
6
Drug Therapy
6
titanium silicide
5
surufatinib
5
irinotecan sucrosofate
5
gemcitabine-oxaliplatin regimen
5
envafolimab
5
camrelizumab
5
atezolizumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
Omacor
×
Clear all
NCT04907864
2021-06-01
MIRACLE
Kyunghee University Medical Center
Phase 2
Unknown
112 enrolled